FDA OK's Addition To Stockpile Of Malaria Drugs For COVID-19

Indonesia Berita Berita

FDA OK's Addition To Stockpile Of Malaria Drugs For COVID-19
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 NPRHealth
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 63%

Chloroquine and hydroxycloroquine got the Food and Drug Administration's go-ahead to be put in the nation's strategic storehouses. But the drugs haven't been approved to treat coronavirus patients.

The Food and Drug Administration has authorized two malaria — chloroquine and hydroxychloroquine — to be added to the national emergency stockpile for use in responding to COVID-19.Photo Illustration by John Phillips/Getty Images

two malaria drugs"emergency use authorization" for the treatment of COVID-19. The move makes it easier to add the medicines to the strategic stockpile, which can be drawn upon in the current public health emergency. But gold standard clinical trials in the United States only just got underway. Preliminary results from those studies aren't expected for weeks or months.

"This is not FDA approval of hydroxychloroquine or chloroquine for the treatment of COVID-19," says epidemiologistwho is leading Massachusetts General Hospital's COVID-19 treatment task force."There's an epidemic of misinformation out there, and we need to combat that."

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

NPRHealth /  🏆 144. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

FDA eases restrictions on mask-sterilizing technology amid coronavirus shortagesFDA eases restrictions on mask-sterilizing technology amid coronavirus shortagesOfficials are scrambling for the N95 masks and other protective equipment for health care workers as the number of COVID-19 cases is expected to spike.
Baca lebih lajut »

FDA approves 5-minute coronavirus test by Abbott LabsFDA approves 5-minute coronavirus test by Abbott LabsAbbott Laboratories is unveiling a coronavirus test that can tell if someone is infected in as little as five minutes, and is so small and portable it can be used in almost any healthcare setting.
Baca lebih lajut »

Ohio governor criticizes Trump administration on FDA mask rulingOhio governor criticizes Trump administration on FDA mask rulingThe Trump administration has approved the first system for sterilizing specialized face masks — but the decision drew a quick rebuke from Ohio’s Republican governor
Baca lebih lajut »

FDA approves new 15-minute coronavirus testFDA approves new 15-minute coronavirus testThe test can deliver "results in as little as five minutes and negative results in 13 minutes," its developer, Abbott, said in a statement.
Baca lebih lajut »

FDA authorizes 15-minute coronavirus testFDA authorizes 15-minute coronavirus testFederal health officials on Friday approved a coronavirus test that can provide results in less than 15 minutes, using the same technology that powers some rapid flu tests.
Baca lebih lajut »

FDA issues emergency authorization of anti-malaria drug for coronavirus careFDA issues emergency authorization of anti-malaria drug for coronavirus careThe Food and Drug Administration issued an emergency use authorization for decades-old malaria drugs championed by President Donald Trump for coronavirus treatment despite scant evidence
Baca lebih lajut »



Render Time: 2025-03-06 12:22:28